Skip to main content
Explore URMC

menu

Breast Cancer: Radiation Therapy with the Oral Drug Olaparib

Research Question:
How well does radiation therapy with or without olaparib work in treating patients with inflammatory breast cancer?

Basic Study Information

Purpose:
This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether radiation therapy with or without olaparib may work better in treating patients with inflammatory breast cancer.

Location: University of Rochester Medical Center
Study Reference #: CBRS18119

Lead Researcher (Principal Investigator)

Lead Researcher: Ajay Dhakal

Study Contact Information

Study Coordinator: Kathryn Corcoran
Phone: (585) 275-7771
Email: Kathryn_Corcoran@URMC.Rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search